Event Details:
HKU Demo Day offers a dynamic platform where promising startups will deliver pitches on their business plans and latest progress—serving as an exceptional opportunity to connect with venture capital (VC) investors, who will share valuable feedback to fuel the teams’ growth.
We cordially invite you to join this TSSSU@HKU Special Edition Demo Day, where startup teams that secure private investment commitments through this Demo Day will be fast-tracked to apply for the TSSSU@HKU2026-27 (TSSSU+ track matching fund).
Key Event Highlights:
· Pitch Format: Each startup will deliver a focused 5-minute pitch + 5-minute Q&A to present their vision and progress.
· Investment Opportunities: Investors will select top-performing teams to offer potential investments, with qualified teams gaining access to 1:1 matching funding for the TSSSU+ 2026-27.
· Other Benefits: Selected winning teams will receive co-working space support from iDendron to further their operations.
Let’s anticipate an inspiring showcase of innovation and entrepreneurship!
Date: 23 September 2025 (Tuesday)
Time: 14:00 – 17:30
Venue: Online (due to Typhoon), links will be sent to registrants
Language: English/ Mandarin
Audience Registration Link: https://forms.office.com/r/QsC00tyyMq
Tentative Rundown
| Innovation Week Demo Day (TSSSU@HKU Special Edition) | |
| Time | Description |
| 14:00-14:30 | Reception |
| 14:30-14:40 | Opening Remarks |
| 14:40-15:40 | Pitching Session 1 |
| Advanced Tech Session
-Dotom Technology -EC Innovation Limited -Hay-koze Limited -MattVerse Limited -5D POWER |
|
| 15:40-15:50 | Break |
| 15:50–17:20 | Pitching Session 2 |
| Healthcare Session
-AxileLife -BioEcho Limited -Estelle Limited -Gene to Health Limited -InnoScreen Research Limited -Lifespectrum Technology -L’Ord’Invent Limited -Obpharm Limited -OmniVis Technology Limited |
|
| 17:20-17:30 | Group Photos & Award Presenting |
| 17:30- | Networking |
Showcase startups：
| Company Name (in English) | Short Description | Category | Academic PIC | Representative |
| Dotom Technology | Dotong Technology specializes in embodied intelligence algorithms, with world-leading proprietary camera planning technology. Our solutions power diverse applications, from photography and dynamic inspection to embodied manipulation. Centered on active perception, we aim to become the key algorithmic infrastructure provider of the embodied intelligence era, empowering a wide range of downstream tasks. | Engineering | Prof. PAN Jia | Dawei WANG |
| EC Innovation Limited | EC Innovation Limited is constructing a circular planting ecosystem with its breakthrough AIOT electrocatalytic planting solution, treating wastewater into toxic-free and nutrient-balanced irrigating water for different types of plants and crops. Through patented electrocatalytic technology, the irrigating water upcycled by EC Flow System achieves nitrogen cycle restoration, boosts agricultural yield by 30%, improves lifetime of urban plants by 30-50%, and cuts landscaping maintenance cost by 30-50%, while saves 30% water used for irrigation, bringing significant economic and environmental benefits to urban planting and smart agriculture industries. | Engineering | Prof. Edmund TSE | Jackson YIP |
| Hay-koze Limited | 229 million outdoor workers face 19,000 heat-related deaths and 22.85 million occupational injuries annually—a crisis intensifying with rising temperatures [ILO]. Our patented solution is the Air Ring 49 (AR49), the world’s first and award-winning, contactless biomedical cooling additive for safety helmets. At just 155g, AR49 is tested to cool critical head hotspots by up to 5.1°C, headache-free, delivers 15 hours of power, and adapts to any helmet with our proprietary Smart-lock. Unlike waist fans or sweat-soaked cooling jackets, it’s ergonomic, agile, and maintenance-free. With over 350 units already deployed by leading contractors including China State and REC Engineering, and recognition from HKSTP Incubation and the James Dyson Award, AR49 is reshaping the $49B cooling device industry. Our vision: revolutionize headspace cooling and health monitoring—beyond helmets, to hats and even runners—unlocking safer, more agile lifestyles worldwide. | Engineering | Mr. Jeff Li | Mr. Jeff Li |
| MattVerse Limited | Although the new energy industry is growing rapidly, its R&D still relies on trial-and-error, limiting performance and safety improvements. Inspired by semiconductor EDA, MattVerse launched the Battery Design Automation (BDA) platform, integrating AI, quantum chemistry, and multiscale modeling to deliver an end-to-end digital workflow from material discovery to system applications. Since 2023, the company has secured multi-million-dollar financing and commercial orders, proving its technological and market value. Now evolving into BDA 2.0, users can describe needs in natural language, and AI agents will automatically handle tasks such as material design, structural optimization, and performance prediction. With strong potential to expand into semiconductors, chemicals, and advanced materials, MattVerse is driving new energy R&D toward full intelligence and leading digital innovation in manufacturing and materials science. | Engineering | Prof. CHEN Guanhua | Shuguang CHEN |
| 5D POWER | Mission: “5DPower” provides “digitally managed space-time”(5D) power chemistry for high specific capacity, safe and enduring electrochemical power supplies, particularly in demanding and emerging markets, such as low altitude electric vehicles (e.g. EVTOLs).
Challenges: single-power chemistry suffers from various limitations and do not meet the demanding requirements of electric propulsion in EVTOLs Innovative Concept: A “Digitally managed space-time (5D) power” system, integrating: Digitalisation: Integrating “Data, Deep Learning, DFT simulations, Design & Deployment”; Chemistry: optimized power-chemistry to suit varied demanding situations; Cell & Pack: digitally mastered hybrid modular e-power sources; System: adaptable power-trains for long power range; Service: Operando “space-time (5D) power” allocation for optimal fly path, power demand and payload, to maximise benefit. |
Engineering | Prof. GUO Zhengxiao | Prof. GUO Zhengxiao |
| AxileLife | AxileLife Limited is a deep-tech reproductive platform company spun out of The University of Hong Kong. Through advanced imaging and AI, we are redefining how fertility is diagnosed, treated, and optimized. Our three-step product strategy — from sperm diagnostics to intelligent selection to embryo assessment — targets the most critical bottlenecks in Assisted Reproductive Technology (ART). Unlike conventional tools that rely on subjective, manual decisions, our solutions deliver real-time, standardized, and data-driven insights. With clinical pilots launching, patents filed, and early partnerships formed, we are now raising funding to scale product rollout, secure regulatory approvals, and grow our footprint across Asia’s rapidly expanding fertility market. | Biotech | Prof. Kevin TSIA | Michelle LO |
| BioEcho Limited | BioEcho is the world’s first AI-powered wearable echocardiography platform. We have miniaturized conventional ultrasound machines into a coin-sized device, integrated with flexible sensors and advanced AI algorithms to deliver radiation-free, real-time, 24/7 heart monitoring. It can be worn easily during daily life, exercise, elderly care, or clinical nursing. When risks are detected, AI instantly analyzes the signals, reports to the smartphone, and can connect with medical assistance if needed. With this groundbreaking innovation, BioEcho enables early detection and timely intervention in cardiovascular disease. |
Biotech | Dr. TIAN Xinyu | Dr. TIAN Xinyu |
| Estelle Limited | We are a biotech company committed to redefining skin health. By harnessing breakthrough science with stem cell factors, we directly address the root causes of compromised skin. Our solution is designed to intelligently calm immune overreactions and accelerate the skin’s natural healing, effectively rebuilding its protective barrier. The result is clinically observed, significant improvement for those struggling with the discomfort of eczema and the challenges of sensitive skin. | Biotech | Dr. XUAN Yiyi/ CTSCB | Dr. XUAN Yiyi |
| Gene to Health Limited | 2Health AI (2HAI) provides innovation initiative that blends the core technologies of the original Gene-to-Health (G2H) platform with cutting-edge generative foundation models (such as DeepSeek), AI agents, and retrieval-augmented generation (RAG). The result is a comprehensive intelligent-agent platform that unifies multi-omics analysis, disease-risk prediction, and health / genetic counselling in a single solution with GPT-style interface. It integrates personal DNA, omics data, physical-exam reports, medical records, and lifestyle information to generate polygenic risk scores for more than a thousand phenotypes and common diseases. Via interactive dialogue, the platform interprets these risks, offers personalized nutrition, prevention, and intervention advice, and delivers visually rich health reports. We offer technological licencing and subscription service to clients from pan-genomics and healthcare industry. | Biotech | Prof. Pak SHAM | Lane CHEN |
| InnoScreen Research Limited | InnoScreen’s AI-driven Drug Design (AIDD) tools integrate Quantum Chemistry and AI to enhance and accelerate the drug discovery process. Quantum Chemistry, a method that uses Quantum Mechanics to predict chemical bonding, molecular structures, reaction mechanisms, and calculate free energy scores, is the most accurate simulation method available. However, it demands significant computational resources, resulting in slow computation speeds. To overcome this limitation, InnoScreen employs AI to accelerate Quantum Chemistry simulations and reduce computational costs. The AI model learns from high-quality data generated by Quantum Chemistry simulations without relying on experimental data.
InnoScreen’s AIDD tools have demonstrated superior performance compared to traditional computational drug design (CADD) tools and other pure AI-driven tools, as evidenced by their results in various benchmark metrics. Currently, InnoScreen is leveraging its tools to develop its own pipelines. |
Biotech | Dr. YIN Zhenyu/ ABIC | Dr. YIN Zhenyu |
| Lifespectrum Technology | Lifespectrum is a biotechnology company targeting the $1 trillion market of stress and hormonal imbalance. Existing solutions are limited by static health measurements, which fail to capture dynamic hormonal fluctuations. Lifespectrum is developing an advanced digital hormone monitoring platform to enable continuous, real-time insights. Our system utilizes a non-invasive saliva test administered via a portable smart reader equipped with patented biosensing technology to ensure medical-grade accuracy. The collected data is synchronized to a dedicated health application, featuring an AI-powered virtual assistant that provides personalized, evidence-based lifestyle recommendations. The Lifespectrum platform offers comprehensive tools for chronic stress management, women’s hormonal health tracking—including menstrual cycles and menopause—and occupational safety monitoring for professions such as aviation. This solution makes hormonal health management accessible, precise, and data-driven. |
Biotech | Prof. Julian TANNER | WANG Lin |
| L’Ord’Invent Limited |
L’Ord’Invent Limited is a start-up company established in 2024. We develop and refine novel therapeutic strategies for various types of cancers which are managed poorly with the current standard. We are also collaborating with local and overseas universities to conduct preclinical and clinical studies in testing new radiodiagnostics and radioligands in cancer management. | Biotech | Prof. LEE Ho Fun Victor | Prof. LEE Ho Fun Victor |
| Obpharm Limited |
OBPHARM is dedicated to developing innovative peptide- and monoclonal antibody-based therapeutics for obesity and related cardiometabolic renal diseases. With the global prevalence of obesity continuing to rise, there is an urgent need for effective treatments that can improve patient outcomes and reduce the burden of cardiovascular and metabolic diseases. At OBPHARM, we are leveraging cutting-edge technologies and scientific knowledge to identify and develop novel therapeutic targets and interventions. We are currently working on a range of promising therapeutic candidates that target key pathways and mechanisms involved in obesity and metabolic diseases. Our pipeline includes novel peptides and monoclonal antibodies that have demonstrated potent activity in preclinical studies and will revolutionize the field of obesity and cardiometabolic disease treatment. | Biotech | Prof. YU WANG | Prof. YU WANG |
| OmniVis Technology Limited |
Surgical navigation, known as “GPS in the operating room,” aligns real-time imaging (CT/MRI/ultrasound) with surgical tools and anatomy to guide surgeons precisely to targets while protecting healthy tissues. Challenges include accuracy, tissue shift, integration, imaging latency, cost, and training. omniVis technology limited’s 5M AI navigation combines multi-view, marker-free, multi-modal, ML, and mixed reality. It uses RGB sensors (replacing infrared) to cut costs and boost accuracy. Optical-magnetic positioning solves tracking and tissue displacement. AI processes multi-modal data for mixed-reality interaction. The system reduces cost and complexity, enables real-time updates and intuitive control, overcomes latency and training barriers, and redefines precision surgery through adaptive, user-centered design. |
Biotech | Prof. Jason Pui Yin CHEUNG | Weichen QI |